Objectives.

  1. Understand the epidemiology, pathogenesis and treatment of the acute chest syndrom of sickle cell disease
  2. Understand how to regognize fat emboli syndrome and rapidly progressive ACS
  3. Understand future directions in the treatment of ACS

Faculty

Elizabeth S. Klings, MD 
Associate Professor of Medicine 
Director, Pulmonary Hypertenstion Center, Boston University School of Medicine

Dr.  Klings has financial relationship(s) with commercial interest(s) with Grant/Research Support with the following:

Actelion pharmaceuticals, Pfizer, Eiger, Reata, Arena, Bayer and Incyte (all managed by Boston University); UptoDate - royalties

  

Session date: 
Wednesday, October 24, 2018 - 8:00am to 9:00am
Location: 
Chestnut Conference Room 1AB
759 Chestnut St
Springfield, MA 01199
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours
  • 1.00 BCIPE Risk Management

Please login or register to take this course.